Mumbai: Glenmark Pharmaceuticals today said its European subsidiary has launched in the UK its first product - Perindopril tablets - which helps in lowering blood pressure.
Glenmark Generics Ltd has launched the tablets in three strengths - 2, 4 and 8 mg, the parent company said in a filing to the Bombay Stock Exchange.
“We are glad to have our first product for the UK market. We see significant growth potential in this region.” Glenmark Generics Chief Executive Officer Terrance Coughlin said.
Glenmark Generics’s current portfolio in Europe consist of two approved products and eight marketing authorisation applications.
Perindopril Erbumine is being manufactured at the Glenmark Generics plant in Goa, India.